Chief Development and Operations Officer · Nuvectis Pharma, Inc. (NVCT)

Shay Shemesh

A named executive officer of Nuvectis Pharma in every fiscal year CompBrief holds from FY2022 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,586,241

Salary $483,381Stock awards $837,000Bonus $265,860

FY2024: $1,814,813

3rd of 3 named executive officers at Nuvectis Pharma by FY2025 total.

3 named officers on file for Nuvectis Pharma, FY2025

Shay Shemesh’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Nuvectis Pharma’s whole pay program stands against its peers

  • Nuvectis Pharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NVCT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2026 (DEF 14A).

Free

Get Shay Shemesh’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Shay Shemesh compensation by year

Nuvectis Pharma Summary Compensation Table · all 4 fiscal years held
In US dollars, as Nuvectis Pharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024FY2025
Salary$329,268$454,750$468,847$483,381
Bonus$200,000$250,750$257,866$265,860
Stock awards$421,200$857,900$1,088,100$837,000
Option awards$0$0$0—
Non-equity incentive$0$0$0—
Pension and deferred compensation$0$0$0—
All other$0$0$0—
Total$950,468$1,563,400$1,814,813$1,586,241

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Nuvectis Pharma, Inc. DEF 14A filed April 27, 2026, accession 0001104659-26-049476, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Nuvectis Pharma, Inc. filed document, accession 0001104659-26-049476. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

$950K
$1.6M
$1.8M
$1.6M
FY22
FY23
FY24
FY25
SalaryBonusStock awards

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU150,000$1,132,500—
RSU130,000$981,500—
RSU115,000$868,250—
RSU60,000$453,000—
RSU48,399$365,412—

Per the Outstanding Equity Awards at Fiscal Year-End table in Nuvectis Pharma, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Nuvectis Pharma’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Ron BentsurChairman & CEO$2,588,526
Enrique PoradosuChief Scientific & Business Officer$1,586,241
Shay Shemesh · this pageChief Development and Operations Officer$1,586,241

The full Nuvectis Pharma compensation record

free company brief

This page is one person within Nuvectis Pharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Nuvectis Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Shay Shemesh's compensation dossier · One-time report. No refunds.